Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage (LINE) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Lineage (LINE) over the last 3 years, with Q3 2025 value amounting to $4.0 million.

  • Lineage's Gains from Investment Securities fell 7777.78% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 million, marking a year-over-year decrease of 5777.78%. This contributed to the annual value of $46.0 million for FY2024, which is 4838.71% up from last year.
  • Per Lineage's latest filing, its Gains from Investment Securities stood at $4.0 million for Q3 2025, which was down 7777.78% from $14.0 million recorded in Q2 2025.
  • Over the past 5 years, Lineage's Gains from Investment Securities peaked at $19.0 million during Q2 2024, and registered a low of -$10.0 million during Q3 2023.
  • Moreover, its 3-year median value for Gains from Investment Securities was $6.5 million (2024), whereas its average is $6.8 million.
  • As far as peak fluctuations go, Lineage's Gains from Investment Securities skyrocketed by 28000.0% in 2024, and later tumbled by 8888.89% in 2025.
  • Quarter analysis of 3 years shows Lineage's Gains from Investment Securities stood at -$1.0 million in 2023, then surged by 1900.0% to $18.0 million in 2024, then tumbled by 77.78% to $4.0 million in 2025.
  • Its Gains from Investment Securities stands at $4.0 million for Q3 2025, versus $14.0 million for Q2 2025 and $1.0 million for Q1 2025.